PT  - JOURNAL ARTICLE
AU  - Fisher, Terrence
AU  - Evans, Elizabeth
AU  - Mallow, Crystal
AU  - Foster, Amber
AU  - Leonard, John
AU  - Chaney, Marya
AU  - Mekhail, Tarek
AU  - Seetharamu, Nagashree
AU  - Steuer, Conor
AU  - Saba, Nabil F
AU  - Adkins, Douglas
AU  - Thaddeus Beck, J
AU  - Algazi, Alain
AU  - Burtness, Barbara
AU  - Baumgart, Megan
AU  - Hager, Steven
AU  - Chay, Christopher
AU  - Spira, Alexander
AU  - Zauderer, Maurice
TI  - 676 Pepinemab, a semaphorin 4D inhibitor, in combination with pembrolizumab induced formation of organized lymphoid aggregates in phase 1b/2 study for first-line treatment of R/M HNSCC (KEYNOTE-B84)
AID  - 10.1136/jitc-2023-SITC2023.0676
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A767--A767
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A767.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A767.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.